Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
175.84
+0.58 (0.33%)
Feb 17, 2026, 4:00 PM EST - Market closed
Belite Bio Market Cap
Belite Bio has a market cap or net worth of $6.6 billion as of February 18, 2026. Its market cap has increased by 247.64% in one year.
Market Cap
6.60B
Enterprise Value
6.32B
1-Year Change
247.64%
Ranking
Category
Stock Price
$175.84
Market Cap Chart
Since the IPO on April 29, 2022, Belite Bio's market cap has increased from $144.57M to $6.60B, an increase of 4,462.83%. That is a compound annual growth rate of 173.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 6.57B | 9.56% |
| Dec 31, 2025 | 6.00B | 207.97% |
| Dec 31, 2024 | 1.95B | 54.32% |
| Dec 29, 2023 | 1.26B | 68.44% |
| Dec 30, 2022 | 749.63M | 418.52% |
| Apr 29, 2022 | 144.57M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cytokinetics | 8.10B |
| Krystal Biotech | 8.02B |
| Nuvalent | 7.83B |
| Vaxcyte | 7.77B |
| Kymera Therapeutics | 6.59B |
| Rhythm Pharmaceuticals | 6.54B |
| Mirum Pharmaceuticals | 6.17B |
| ImmunityBio | 5.86B |